Buckingham Capital Management (Ohio)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Buckingham Capital Management (Ohio)'s GILD Position: Q1 2018 in Review
Buckingham Capital Management (Ohio) sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 18,594 shares — an estimated $1.33M sold.
Buckingham Capital Management (Ohio) first reported a position in GILD in Q2 2013 and held it in 19 quarters. The position peaked at $1.55M in Q3 2017. 1,563 funds tracked by Wall St. Rank hold GILD as of Q1 2018.
- Buckingham Capital Management (Ohio) reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
- Buckingham Capital Management (Ohio) sold 18,594 Gilead Sciences shares in Q1 2018, an estimated $1.33M.
- Buckingham Capital Management (Ohio) first reported a position in Gilead Sciences in Q2 2013 and held it in 19 quarters.
- Buckingham Capital Management (Ohio)'s Gilead Sciences position peaked at $1.55M in Q3 2017.
- 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.
Based on Buckingham Capital Management (Ohio)'s 13F filing for Q1 2018, filed 11 May 2018.